IPP Bureau

Pfizer seeks EUA from U.S. FDA for Covid-19 drug
Pfizer seeks EUA from U.S. FDA for Covid-19 drug

By IPP Bureau - November 17, 2021

If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2

Biocon Biologics and Viatris announce US launch of Semglee
Biocon Biologics and Viatris announce US launch of Semglee

By IPP Bureau - November 17, 2021

Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes

PM to inaugurate first Global Innovation Summit of Pharmaceuticals sector
PM to inaugurate first Global Innovation Summit of Pharmaceuticals sector

By IPP Bureau - November 17, 2021

The Summit will also witness participation of Union Minister of Health & Family Welfare and Chemicals & Fertilizers Dr. Mansukh Mandaviya

Cipla launches Spirofy for early diagnosis of COPD
Cipla launches Spirofy for early diagnosis of COPD

By IPP Bureau - November 17, 2021

It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)

World’s first Donepezil patch to treat Alzheimer approved in South Korea
World’s first Donepezil patch to treat Alzheimer approved in South Korea

By IPP Bureau - November 17, 2021

Launching in 2022, its availability will be expanded to the global market

U.S FDA authorises EaseVRx, immersive virtual reality for pain relief
U.S FDA authorises EaseVRx, immersive virtual reality for pain relief

By IPP Bureau - November 17, 2021

EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference

Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards
Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards

By IPP Bureau - November 16, 2021

The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards

Pre-diabetes is a much more serious issue in India: Fitterfly
Pre-diabetes is a much more serious issue in India: Fitterfly

By IPP Bureau - November 16, 2021

Two out of three people under the age of 40 are at risk of prediabetes

Biocon Biologics partners with RSSDI to expand insulin access
Biocon Biologics partners with RSSDI to expand insulin access

By IPP Bureau - November 16, 2021

BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children

Vicco Labs moves to sustainable Platina tube packaging
Vicco Labs moves to sustainable Platina tube packaging

By IPP Bureau - November 16, 2021

Platina 250, 300 & 350 Lamitubes have been recognized by the Association of Plastic Recyclers (APR), USA as meeting or exceeding the strict APR HDPE critical guidance criteria on recyclability

Govt allows post-mortem procedure to be performed after sunset
Govt allows post-mortem procedure to be performed after sunset

By IPP Bureau - November 16, 2021

The union health ministry notifies the protocol and this move will also help in organ donation

International Society of Pharmacovigilance opens South Asia chapter
International Society of Pharmacovigilance opens South Asia chapter

By IPP Bureau - November 16, 2021

The aim is to support Pharmacovigilance programme across the countries in the region

Research uncovers challenges for people with vascular disease
Research uncovers challenges for people with vascular disease

By IPP Bureau - November 16, 2021

Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis

Vakrangee to distribute Corival products
Vakrangee to distribute Corival products

By IPP Bureau - November 15, 2021

Vakrangee’s distribution network across rural India will help penetrate underserved markets

Wadia Hospital, Mumbai introduces tests for cystic fibrosis
Wadia Hospital, Mumbai introduces tests for cystic fibrosis

By IPP Bureau - November 15, 2021

This test is inexpensive and results are available immediately as compared to the genetic test

Latest Stories

Interviews

Packaging